48,860
edits
Difference between revisions of "Neuroendocrine tumour of the pancreas"
Jump to navigation
Jump to search
Neuroendocrine tumour of the pancreas (view source)
Revision as of 18:06, 13 March 2014
, 18:06, 13 March 2014→IHC
(→IHC) |
|||
| Line 91: | Line 91: | ||
*Synaptophysin +ve. | *Synaptophysin +ve. | ||
*CD56 +ve. | *CD56 +ve. | ||
Functional tumours: | |||
*Insulin. | |||
*Glucagon. | |||
*Somatostatin. | |||
*Gastrin. | |||
A panel: | A panel: | ||
*Chromogranin, synaptophysin, CD10, PR, beta-catenin, CK7, pankeratin, Ki-67, CK19. | *Chromogranin, synaptophysin, CD10, PR, beta-catenin, CK7, pankeratin, Ki-67, CK19. | ||
Notes: | |||
*''CK19'' should '''not''' be confused with ''CA19-9''. | *''CK19'' should '''not''' be confused with ''CA19-9''. | ||
*If the tumour is '''not''' functional (clinically) one can forgo the stains for functional tumours. | |||
==Sign out== | ==Sign out== | ||